ONC — Oncimmune Holdings Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- £1.27m
- £5.55m
- £2.74m
Annual cashflow statement for Oncimmune Holdings, fiscal year end - August 31st, GBP millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 15 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.78 | -5.7 | -11.6 | 4.33 | -4.11 |
| Depreciation | |||||
| Non-Cash Items | 0.188 | 1.77 | 3.34 | -10.4 | 1.28 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.192 | -1.34 | -0.293 | -1.71 | -0.816 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.9 | -4.53 | -6.87 | -6.79 | -3.38 |
| Capital Expenditures | -0.236 | -1.07 | -0.931 | -0.031 | -0.009 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.583 | 0.215 | 0 | 11.6 | 1.17 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.347 | -0.856 | -0.931 | 11.6 | 1.16 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.46 | 9.78 | 0.652 | -3.02 | -0.071 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.12 | 4.39 | -7.21 | 1.78 | -2.36 |